Vimarsana
Biggest News Aggregation in the World

Page 3 - Micro Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Micro Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Micro Lab Today - Breaking & Trending Today

I-T Dept raids Dolo-650 manufacturer Micro Lab's office - Vimarsana News

I-T Dept raids Dolo-650 manufacturer Micro Lab's office

The Income Tax Department conducted raids on the office of popular drug Dolo-650 manufacturer Micro Labs Limited located here on Wednesday.

Paracetamol Wars: Amid Dolo's rising popularity, Crocin defends turf - Vimarsana News

Paracetamol Wars: Amid Dolo's rising popularity, Crocin defends turf

A recent print ad for GSK's Crocin 650 has created buzz. We take a look at this fascinating rivalry that holds a mirror to our times.

Source: afaqs.com
Jaundice Meter Market Strategic Assessment, Growth Analysis and Research Outlook 2021-2026 – KSU - Vimarsana News

Jaundice Meter Market Strategic Assessment, Growth Analysis and Research Outlook 2021-2026 – KSU

The report studies the Jaundice Meter Market with many aspects of the industry like the market size, status, trends, and forecast, the report also pro

In India, Drugs for COVID Are Being Tested, Approved in Ways That Should Worry Us - Vimarsana News

In India, Drugs for COVID Are Being Tested, Approved in Ways That Should Worry Us

In India, Drugs for COVID Are Being Tested, Approved in Ways That Should Worry Us 25/05/2021 Representative photo: analuisa gamboa/Unsplash Mumbai: Since the start of the COVID-19 pandemic last year, researchers around the world have evaluated scores of drugs and therapeutic techniques for the disease. Even according to the Clinical Trial Registry of India (CTRI), researchers in the country are testing everything from inhaled camphor and ajwain to Viagra. This may be desperation, given the brutality of India’s second COVID-19 outbreak. It is also worthwhile in more ways than one ...

Pfizer Alleges Micro Labs Infringing on Xeljanz Patents - Vimarsana News

Pfizer Alleges Micro Labs Infringing on Xeljanz Patents

Health your username March 12, 2021 On Thursday in the District of Delaware, Pfizer Inc. and its subsidiaries filed a complaint against Micro Labs Ltd. and its subsidiary, alleging infringement of its patents for drug Xeljanz. Pfizer holds the new drug application (NDA) for 10 mg tofacitinib citrate tablets, under the brand name Xeljanz, used to treat adults with ulcerative colitis, the complaint said. The patents-in-suit corresponding to Xeljanz are U.S. Patents Nos. RE41,783 and 6,965,027, which are set to expire Dec. 8, 2025, and March 25, 2023, respectively, according to the Food and Drug...